8-63065904-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_000370.3(TTPA):c.552G>A(p.Thr184Thr) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,613,674 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000370.3 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151994Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251242Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135790
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461562Hom.: 0 Cov.: 30 AF XY: 0.0000179 AC XY: 13AN XY: 727086
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152112Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74362
ClinVar
Submissions by phenotype
Familial isolated deficiency of vitamin E Pathogenic:5
Variant summary: TTPA c.552G>A (p.Thr184Thr) alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: One predicts the variant abolishes a 5' splicing donor site, two predict the variant weakens a 5' donor site, and two predict the variant creates a 3' acceptor site. At least two publications report experimental evidence that this variant affects mRNA splicing, producing a shortened mRNA transcript which lacks exon 3 (Tamaru_1997, Schuelke_1999). The mis-splicing is predicted to result in a shift in reading frame and a premature stop codon producing a truncated protein lacking the domains encoded by exons 3 to 5 (Schuelke_1999). The variant allele was found at a frequency of 2e-05 in 251242 control chromosomes. c.552G>A has been reported in the literature in individuals affected with Ataxia With Vitamin E Deficiency (Tamaru_1997, Schuelke_1999). These data indicate that the variant is likely to be associated with disease. Three clinical diagnostic laboratories and one research institution have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
- -
- -
not provided Pathogenic:2
DNA sequence analysis of the TTPA gene demonstrated a sequence change, c.552G>A, in exon 3 that results in a synonymous amino acid change, p.Thr184Thr, in the apparent homozygous state. This sequence change occurs at the last base of exon 3 and in-silico splice prediction programs predict that this sequence change disrupts the canonical splice donor site at intron 3. RNA studies have demonstrated that this sequence change leads to the creation of an abnormal transcript lacking exon 3, and results in a premature stop codon (PMID: 9270601). This sequence change has been previously described in the homozygous state in individuals with ataxia with isolated vitamin E deficiency (PMID: 9270601, 9931538). This sequence change has been described in the gnomAD database in a total of 5 individuals, which corresponds to a frequency of 0.002% in the overall population (dbSNP rs181109321). Based on these collective evidences, this variant is considered likely pathogenic. -
This sequence change affects codon 184 of the TTPA mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the TTPA protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs181109321, gnomAD 0.004%). This variant has been observed in individuals with TTPA-related conditions (PMID: 9270601, 9931538). ClinVar contains an entry for this variant (Variation ID: 374211). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in exon 3 skipping and introduces a premature termination codon (PMID: 9931538). The resulting mRNA is expected to undergo nonsense-mediated decay. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Ataxia, Friedreich-like, with isolated vitamin E deficiency Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at